Brain-Responsive Neurostimulation Reduces Focal Seizures by 82% at Three Years

Managing drug-resistant focal epilepsy remains a significant clinical challenge, as approximately one-third of patients continue to experience seizures despite optimal antiseizure medication regimens [1, 2]. When resective surgery is not an option, clinicians often utilize neuromodulation therapies such as vagus nerve stimulation, deep brain stimulation, or responsive neurostimulation to reduce seizure burden [3, 4]. Meta-analyses of these interventions show that intracranial modalities (devices with electrodes implanted directly within the cranium) achieve higher one-year seizure reduction rates compared to extracranial vagus nerve stimulation [1, 3]. Long-term prospective data further support these findings, reporting sustained improvements in seizure frequency and a low rate of sudden unexplained death in epilepsy among patients treated with direct brain stimulation [2]. Given these outcomes, current expert consensus from the International League Against Epilepsy recommends that clinicians offer a surgical evaluation to every patient as soon as drug resistance is established to optimize long-term prognosis [5]. A recent prospective study now offers fresh insights into the real-world effectiveness of responsive neurostimulation, providing clinicians with updated expectations for long-term seizure control and patient safety.